Latest Schedule 13G passive stakes

Nicholas Giannuzzi has filed an amendment to a Schedule 13G, correcting an underreported number of shares in The ONE Group Hospitality, Inc.

Jane Street Group, LLC and its affiliates have reported beneficial ownership of 5,502,994 shares, representing 5.1% of First Solar, Inc.'s common stock, as of June 30, 2026.

Morgan Stanley has reported a decrease in its beneficial ownership of Bed Bath & Beyond, Inc. common stock to 5.4%.

Morgan Stanley has reported a decrease in its beneficial ownership of Bed Bath & Beyond, Inc. common stock to 5.4%.

GCM Grosvenor Inc. reports significant beneficial ownership of Class A Common Stock by Michael Jay Sacks and associated entities, totaling over 69% as of June 30, 2026.

Dodge & Cox has reported its beneficial ownership of Willis Towers Watson ordinary shares, maintaining an 8.5% stake as of June 30, 2026.

Van Eck Associates Corporation has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Alamos Gold Inc. common stock.

Dodge & Cox reports maintaining a 5.7% beneficial ownership in V. F. CORPORATION's common stock as of June 30, 2026.

Dodge & Cox reports a 7.0% beneficial ownership of Roper Technologies' common stock as of June 30, 2026.

Morgan Stanley has reported a decrease in its beneficial ownership of BBB Foods Inc. Class A Common Shares to below the 5% threshold.

Morgan Stanley has reported a decrease in its beneficial ownership of BBB Foods Inc. Class A Common Shares to below the 5% threshold.

Paradigm Capital Management, Inc. has amended its Schedule 13G filing to report beneficial ownership of 3,439,098 shares, representing 4.42% of Integra Lifesciences Holdings Corp.'s common stock as of March 31, 2026.

Atlas Venture Fund X, L.P. and related entities have reported a change in their beneficial ownership of Kymera Therapeutics, Inc. common stock, now holding 3.4% collectively.

Dodge & Cox has filed a Schedule 13G, indicating a minor beneficial ownership of LyondellBasell Industries N.V. ordinary shares.

Saba Capital Management, L.P. and associated entities have updated their Schedule 13G filing, reporting beneficial ownership of 14.35% of PIMCO Dynamic Income Strategy Fund's common shares.

Saba Capital Management, L.P. and its affiliates have reported a beneficial ownership of 10.3% in Vertical Aerospace Ltd., primarily through ordinary shares and warrants.

Dodge & Cox has reported beneficial ownership of 5.3% of Cemex's American Depositary Shares, signaling a substantial investment.

Morgan Stanley reports a change in its beneficial ownership of AMN Healthcare Services, Inc. common stock, now holding 5.4% of the class.

Morgan Stanley reports a change in its beneficial ownership of AMN Healthcare Services, Inc. common stock, now holding 5.4% of the class.

Saba Capital Management, L.P. and its affiliates have reported beneficial ownership of 4.25% of TaskUs, Inc. common shares.

Dodge & Cox has reported beneficial ownership of 50,012,765 shares, representing 3.9% of CVS Health Corporation's common stock, as of June 30, 2026.

Dodge & Cox reports a 12.6% beneficial ownership of Charter Communications, Inc. Class A Common Stock as of June 30, 2026, with no changes in control intent.

Artisan Partners, through its various entities, has filed a Schedule 13G, reporting a beneficial ownership of 14.8% in Axalta Coating Systems Ltd. common shares as of June 30, 2026.

Artisan Partners Asset Management Inc. and its affiliates have reported a beneficial ownership stake of 5.1% in iRhythm Holdings, Inc.

Artisan Partners, through its various entities, has reported a beneficial ownership of 5.5% of Radware Ltd.'s ordinary shares as of June 30, 2026.

Artisan Partners reports a shift in its beneficial ownership of Willis Towers Watson ordinary shares, now holding 5.9% as of June 30, 2026.

Artisan Partners Asset Management Inc. and its affiliates have reported a 0.0% beneficial ownership of Sensata Technologies Holding PLC ordinary shares, indicating a full divestment.

Artisan Partners, through its various entities, has reported a beneficial ownership of 7.7% in Twist Bioscience Corporation's common shares as of June 30, 2026.

Artisan Partners, through its various entities, has disclosed beneficial ownership of 4.2% of Ascendis Pharma A/S's ordinary shares as of June 30, 2026.

Artisan Partners, through its various entities, has reported beneficial ownership of 2,601,598 ordinary shares, representing 5.2% of Stevanato Group S.p.A., as of June 30, 2026.